A new report demonstrates that female-dominated inventor teams in biomedical sciences are more likely to invent...

Home / News / Pearce IP Blog
A new report demonstrates that female-dominated inventor teams in biomedical sciences are more likely to invent...
23 Jun 21 | US | Genentech announced that the FDA has accepted the BLA for its Port Delivery System with ranibizumab...
10 June 21 | The UK's NICE published final draft guidance recommending adalimumab, etanercept and infliximab for the...
07 Jun 21 | Celltrion launched Remsima SC® (subcutaneous infliximab biosimilar) in Canada. Remsima SC® is indicated...
Pearce IP recently reported on recommendations made by an independent review into the Australian patent system to...
31 May 21 | Celltrion will launch Yuflyma® (biosimilar adalimumab) in the EU in June, as reported by the Korea Herald....
24 May 21 | IN | Zydus Cadila announced it has launched Ujvira (trastuzumab emtansine) in India. Ujvira is an antibody...
12 May 21 | Celltrion released its Q1 2020 financial results, reporting that YoY sales of Celltrion biosimilars...
11 May | US | Alvotech filed a federal lawsuit against AbbVie in the US District Court of the Eastern District of...
On 11 May 2021, Treasurer Josh Frydenberg announced that the 2021-2022 Australian Federal Budget would introduce a...
IP waivers alone are nowhere near enough to increase COVID-19 vaccine access for developing countries, but US support...
01 May 21 | Samsung Bioepis announced a new study demonstrating the structural, physicochemical and biological...
In light of the COVID-19 vaccine supply shortages in Australia, it was refreshing to hear NSW Premier Gladys...
23 April | Boehringer Ingelheim announced results from a Ph III switching study of Cyltezo® (biosimilar adalimumab)...
As a second wave of COVID-19 ravages India, the rest of the world should be paying close attention to the reported...
15 April 21 | US | The Centre for Biosimilars reported a poster presented at AMCP 2021 shows a New York state Medicaid...